These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 18521197)

  • 1. Enhanced MDM2 Oncoprotein Expression in Soft Tissue Sarcoma: Several Possible Regulatory Mechanisms.
    Pollock RE; Lang A; El-Naggar AK; Radinsky R; Hung MC
    Sarcoma; 1997; 1(1):23-9. PubMed ID: 18521197
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MDM2 gene amplification and transcript levels in human sarcomas: relationship to TP53 gene status.
    Flørenes VA; Maelandsmo GM; Forus A; Andreassen A; Myklebost O; Fodstad O
    J Natl Cancer Inst; 1994 Sep; 86(17):1297-302. PubMed ID: 8064888
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular abnormalities of mdm2 and p53 genes in adult soft tissue sarcomas.
    Cordon-Cardo C; Latres E; Drobnjak M; Oliva MR; Pollack D; Woodruff JM; Marechal V; Chen J; Brennan MF; Levine AJ
    Cancer Res; 1994 Feb; 54(3):794-9. PubMed ID: 8306343
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Amplification of the MDM2 gene, but not expression of splice variants of MDM2 MRNA, is associated with prognosis in soft tissue sarcoma.
    Bartel F; Meye A; Würl P; Kappler M; Bache M; Lautenschläger C; Grünbaum U; Schmidt H; Taubert H
    Int J Cancer; 2001 May; 95(3):168-75. PubMed ID: 11307150
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MDM2 and CDK4 gene amplification in Ewing's sarcoma.
    Ladanyi M; Lewis R; Jhanwar SC; Gerald W; Huvos AG; Healey JH
    J Pathol; 1995 Feb; 175(2):211-7. PubMed ID: 7738717
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Colony formation of soft tissue sarcoma cells is inhibited by lipid-mediated antisense oligodeoxynucleotides targeting the human mdm2 oncogene.
    Meye A; Würl P; Bache M; Bartel F; Grünbaum U; Mansa-ard J; Schmidt H; Taubert H
    Cancer Lett; 2000 Feb; 149(1-2):181-8. PubMed ID: 10737722
    [TBL] [Abstract][Full Text] [Related]  

  • 7. mdm2 mRNA level is a prognostic factor in soft tissue sarcoma.
    Taubert H; Koehler T; Meye A; Bartel F; Lautenschläger C; Borchert S; Bache M; Schmidt H; Würl P
    Mol Med; 2000 Jan; 6(1):50-9. PubMed ID: 10803408
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Analysis of p53 mutational events and MDM2 amplification in canine soft-tissue sarcomas.
    Nasir L; Rutteman GR; Reid SW; Schulze C; Argyle DJ
    Cancer Lett; 2001 Dec; 174(1):83-9. PubMed ID: 11675155
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The MDM2 gene amplification database.
    Momand J; Jung D; Wilczynski S; Niland J
    Nucleic Acids Res; 1998 Aug; 26(15):3453-9. PubMed ID: 9671804
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Growth reduction of a xenotransplanted human soft tissue sarcoma by MDM2 antisense therapy via implanted osmotic minipumps.
    Würl P; Bartel F; Meye A; Kappler M; Bache M; Schmidt H; Schönfelder M; Taubert H
    Int J Oncol; 2002 May; 20(5):1087-93. PubMed ID: 11956608
    [TBL] [Abstract][Full Text] [Related]  

  • 11. p53 Mutation and MDM2 amplification in human soft tissue sarcomas.
    Leach FS; Tokino T; Meltzer P; Burrell M; Oliner JD; Smith S; Hill DE; Sidransky D; Kinzler KW; Vogelstein B
    Cancer Res; 1993 May; 53(10 Suppl):2231-4. PubMed ID: 8387391
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A comparative study of P53/MDM2 genes alterations and P53/MDM2 proteins immunoreactivity in soft-tissue sarcomas.
    Rieske P; Bartkowiak JK; Szadowska AM; Olborski B; Harezga-Bal B; Debiec-Rychter M
    J Exp Clin Cancer Res; 1999 Sep; 18(3):403-16. PubMed ID: 10606188
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High prognostic significance of Mdm2/p53 co-overexpression in soft tissue sarcomas of the extremities.
    Würl P; Meye A; Schmidt H; Lautenschläger C; Kalthoff H; Rath FW; Taubert H
    Oncogene; 1998 Mar; 16(9):1183-5. PubMed ID: 9528860
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Loss of heterozygosity at 12q14-15 often occurs in stage I soft tissue sarcomas and is associated with MDM2 amplification in tumors at various stages.
    Taubert H; Schuster K; Brinck U; Bartel F; Kappler M; Lautenschläger C; Bache M; Trump C; Schmidt H; Holzhausen HJ; Würl P; Schlott T
    Mod Pathol; 2003 Nov; 16(11):1109-16. PubMed ID: 14614050
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nutlin-3a efficacy in sarcoma predicted by transcriptomic and epigenetic profiling.
    Pishas KI; Neuhaus SJ; Clayer MT; Schreiber AW; Lawrence DM; Perugini M; Whitfield RJ; Farshid G; Manavis J; Chryssidis S; Mayo BJ; Haycox RC; Ho K; Brown MP; D'Andrea RJ; Evdokiou A; Thomas DM; Desai J; Callen DF; Neilsen PM
    Cancer Res; 2014 Feb; 74(3):921-31. PubMed ID: 24336067
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oncoprotein MDM2 conceals the activation domain of tumour suppressor p53.
    Oliner JD; Pietenpol JA; Thiagalingam S; Gyuris J; Kinzler KW; Vogelstein B
    Nature; 1993 Apr; 362(6423):857-60. PubMed ID: 8479525
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cell cycle regulatory functions of the human oncoprotein MDM2.
    Deb SP
    Mol Cancer Res; 2003 Dec; 1(14):1009-16. PubMed ID: 14707284
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of MDM2 during mammary tumorigenesis.
    Pinkas J; Naber SP; Butel JS; Medina D; Jerry DJ
    Int J Cancer; 1999 Apr; 81(2):292-8. PubMed ID: 10188733
    [TBL] [Abstract][Full Text] [Related]  

  • 19. p53 mutation and MDM2 amplification are rare even in human papillomavirus-negative cervical carcinomas.
    Ikenberg H; Matthay K; Schmitt B; Bauknecht T; Kiechle-Schwarz M; Göppinger A; Pfleiderer A
    Cancer; 1995 Jul; 76(1):57-66. PubMed ID: 8630877
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Significance of HDMX-S (or MDM4) mRNA splice variant overexpression and HDMX gene amplification on primary soft tissue sarcoma prognosis.
    Bartel F; Schulz J; Böhnke A; Blümke K; Kappler M; Bache M; Schmidt H; Würl P; Taubert H; Hauptmann S
    Int J Cancer; 2005 Nov; 117(3):469-75. PubMed ID: 15906355
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.